India’s health ministry on Monday wrote to states asking them to administer second AstraZeneca coronavirus vaccine doses to recipients within four to eight weeks, from the current guideline of four to six weeks.
“The recommendation has been revised to provide the 2nd dose of COVISHIELD at 4-8 weeks’ interval after the 1st dose, instead of earlier practiced interval of 4-6 weeks,” the ministry said in a statement, using the brand name for the vaccine made locally by the Serum Institute of India.
India’s Serum Institute delays vaccine shipments to Brazil, Morocco, SaudiThe Serum Institute of India (SII) has told Brazil, Saudi Arabia and Morocco that further supplies of the AstraZeneca COVID-19 vaccine will be delayed ... Coronavirus
India backs AstraZeneca COVID-19 vaccine as cases soarIndia said on Wednesday its coronavirus immunization campaign would continue with “full rigor” despite some concerns in Europe about the safety of the ... Coronavirus
India’s drug regulator eases norms for use of homegrown COVID-19 vaccineAn expert panel of India’s drug regulator has recommended relaxing norms for the use of a government-backed coronavirus vaccine after it was found to ... Coronavirus
Pfizer seeks to make vaccine in India if assured of faster clearance, export freedomPfizer Inc has told the Indian government it wants to produce its coronavirus vaccine locally if assured of faster regulatory clearance andfreedom on ... Coronavirus